Literature DB >> 29595355

Irreversible electroporation for the treatment of cardiac arrhythmias.

Alan Sugrue1, Elad Maor2, Antoni Ivorra3, Vaibhav Vaidya1, Chance Witt1, Suraj Kapa1, Samuel Asirvatham1.   

Abstract

INTRODUCTION: Cardiac ablation is an established treatment modality for the management of patients with cardiac arrhythmias. Current approaches to cardiac ablation employ thermal based energy to achieve lesions (damage) within the heart. There are many shortcomings and limitations of thermal based approaches. Electroporation (DC energy) is a non-thermal alternative approach to ablation that has shown significant promise in animal studies. Areas covered: An extensive review of the literature on the application of electroporation for ablation (both cardiac and collateral cardiac tissue) was undertaken. This review explores irreversible electroporation as a cardiac ablation modality. Specifically, it focuses and explains the biophysics of electroporation, the limitations of current thermal based approaches and examines the current data published on electroporation cardiac ablation. Expert commentary: Electroporation is a fast-growing novel ablation modality that has many advantages over current thermal based approaches. Current research in animal models shows its can be safely and efficaciously applied to the heart. Although further research is required, electroporation represents an appealing option for the ablation cardiac arrhythmias.

Entities:  

Keywords:  DC energy; Electroporation; atrial fibrillation; cardiac ablation; ventricular arrhythmias

Mesh:

Year:  2018        PMID: 29595355     DOI: 10.1080/14779072.2018.1459185

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  6 in total

1.  EView: An electric field visualization web platform for electroporation-based therapies.

Authors:  Enric Perera-Bel; Carlos Yagüe; Borja Mercadal; Mario Ceresa; Natalie Beitel-White; Rafael V Davalos; Miguel A González Ballester; Antoni Ivorra
Journal:  Comput Methods Programs Biomed       Date:  2020-08-02       Impact factor: 5.428

2.  An experimental system for real-time fluorescence recordings of cell membrane changes induced by electroporation.

Authors:  Ioan Tivig; Tudor Savopol; Eugenia Kovacs; Mihaela G Moisescu
Journal:  Eur Biophys J       Date:  2019-12-23       Impact factor: 1.733

3.  AC Pulsed Field Ablation Is Feasible and Safe in Atrial and Ventricular Settings: A Proof-of-Concept Chronic Animal Study.

Authors:  Guido Caluori; Eva Odehnalova; Tomasz Jadczyk; Martin Pesl; Iveta Pavlova; Lucia Valikova; Steffen Holzinger; Veronika Novotna; Vladimir Rotrekl; Ales Hampl; Michal Crha; Dalibor Cervinka; Zdenek Starek
Journal:  Front Bioeng Biotechnol       Date:  2020-12-03

4.  Safety and chronic lesion characterization of pulsed field ablation in a Porcine model.

Authors:  Mark T Stewart; David E Haines; Damijan Miklavčič; Bor Kos; Nicole Kirchhof; Noah Barka; Lars Mattison; Matt Martien; Birce Onal; Brian Howard; Atul Verma
Journal:  J Cardiovasc Electrophysiol       Date:  2021-03-10

5.  Electroporation Parameters for Human Cardiomyocyte Ablation In Vitro.

Authors:  Jara M Baena-Montes; Tony O'Halloran; Cormac Clarke; Kevin Donaghey; Eoghan Dunne; Martin O'Halloran; Leo R Quinlan
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-28

6.  Feasibility of selective cardiac ventricular electroporation.

Authors:  Alan Sugrue; Vaibhav R Vaidya; Christopher Livia; Deepak Padmanabhan; Anas Abudan; Ameesh Isath; Tyra Witt; Christopher V DeSimone; Paul Stalboerger; Suraj Kapa; Samuel J Asirvatham; Christopher J McLeod
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.